^Yamada J, Sugimoto Y, Noma T, Yoshikawa T (1998). „Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.”.Eur J Pharmacol.359 (1): 81—86.PMID9831297.doi:10.1016/S0014-2999(98)00617-7.
^Wright, CE; Angus, JA (1989). „5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets.”.Journal of cardiovascular pharmacology.13 (4): 557—64.PMID2470992.
^Saxena, PR; Lawang, A (1985). „A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.”.Archives internationales de pharmacodynamie et de therapie.277 (2): 235—52.PMID2933009.